Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,947 | 135 | 88.0% |
| Education | $400.36 | 9 | 12.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $458.85 | 12 | $0 (2021) |
| GlaxoSmithKline, LLC. | $452.85 | 27 | $0 (2023) |
| Genentech USA, Inc. | $348.30 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $268.52 | 18 | $0 (2023) |
| Astellas Pharma US Inc | $182.37 | 5 | $0 (2019) |
| Genentech, Inc. | $152.00 | 4 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $150.13 | 3 | $0 (2020) |
| Grifols USA, LLC | $145.28 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.61 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $116.69 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $668.94 | 26 | Regeneron Healthcare Solutions, Inc. ($96.02) |
| 2022 | $51.54 | 3 | GlaxoSmithKline, LLC. ($33.80) |
| 2021 | $156.37 | 4 | JAZZ PHARMACEUTICALS INC. ($110.22) |
| 2020 | $136.70 | 8 | GlaxoSmithKline, LLC. ($31.88) |
| 2019 | $689.54 | 34 | Astellas Pharma US Inc ($154.35) |
| 2018 | $774.86 | 39 | Genentech USA, Inc. ($188.00) |
| 2017 | $869.79 | 30 | Jazz Pharmaceuticals Inc. ($236.16) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $57.48 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 08/21/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Respiratory | ||||||
| 08/17/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Immunology | ||||||
| 08/16/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/14/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 08/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Respiratory | ||||||
| 06/02/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Immunology | ||||||
| 06/01/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/17/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
| 04/26/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 04/03/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $39.41 | General |
| 04/02/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $43.91 | General |
| 03/09/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 02/28/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Respiratory | ||||||
| 02/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Cardio-pulmonary | ||||||
| 02/07/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 268 | 369 | $81,692 | $23,847 |
| 2022 | 18 | 474 | 597 | $194,499 | $51,506 |
| 2021 | 12 | 387 | 633 | $345,985 | $89,645 |
| 2020 | 19 | 563 | 884 | $383,231 | $100,925 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 100 | $10,494 | $6,158 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 59 | $18,912 | $5,029 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 65 | $14,085 | $3,848 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $12,710 | $2,866 | 22.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 48 | $5,519 | $1,833 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,891 | $1,669 | 24.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 14 | 14 | $7,746 | $1,266 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $2,036 | $446.90 | 21.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 18 | 18 | $1,520 | $422.29 | 27.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 17 | 17 | $1,779 | $308.88 | 17.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 92 | $27,324 | $7,543 | 27.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 32 | 38 | $32,394 | $6,159 | 19.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 15 | 34 | $22,100 | $5,728 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 42 | $17,892 | $5,625 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 50 | $15,900 | $4,937 | 31.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $16,588 | $4,614 | 27.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 83 | $8,632 | $4,591 | 53.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 20 | 20 | $15,370 | $3,115 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 41 | $8,815 | $2,513 | 28.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $9,760 | $2,357 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,846 | $1,522 | 22.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 36 | 36 | $2,352 | $701.45 | 29.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 12 | 12 | $3,987 | $534.93 | 13.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 19 | 19 | $1,652 | $467.33 | 28.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 24 | 24 | $2,330 | $431.81 | 18.5% |
About Dr. Michelle Perello, DO
Dr. Michelle Perello, DO is a Pulmonary Disease healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396709655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Perello, DO has received a total of $3,348 in payments from pharmaceutical and medical device companies, with $668.94 received in 2023. These payments were reported across 144 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,947).
As a Medicare-enrolled provider, Perello has provided services to 1,692 Medicare beneficiaries, totaling 2,483 services with total Medicare billing of $265,923. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Chesapeake, VA
- Active Since 04/13/2006
- Last Updated 07/21/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1396709655
Products in Payments
- Xyrem (Drug) $306.68
- Esbriet (Biological) $285.63
- NUCALA (Biological) $187.59
- ANORO (Drug) $153.59
- DUPIXENT (Biological) $153.50
- XYWAV (Drug) $110.22
- Prolastin-C Liquid (Biological) $105.34
- Xolair (Biological) $97.34
- XOLAIR (Biological) $91.84
- FASENRA (Drug) $78.91
- TRELEGY ELLIPTA (Drug) $72.30
- The Vest System Model 105 Home Care (Device) $69.15
- STIOLTO RESPIMAT (Drug) $57.34
- ORENITRAM (Drug) $56.74
- PURIFIED CORTROPHIN GEL (Drug) $54.88
- FASENRA (Biological) $53.57
- SYMBICORT (Drug) $50.88
- BREZTRI (Drug) $50.85
- SMARTVEST (Device) $45.63
- YUPELRI (Drug) $45.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chesapeake
Carlos Silva, M.d, M.D
Pulmonary Disease — Payments: $281,208
Manojkumar Patel, Md, MD
Pulmonary Disease — Payments: $12,628
Dr. Haresh Patel, M.d, M.D
Pulmonary Disease — Payments: $3,384
Mrs. Vandana Patel, Md, MD
Pulmonary Disease — Payments: $3,037
Eric Freeman, Md, MD
Pulmonary Disease — Payments: $2,061
Leah Zuniega, Md, MD
Pulmonary Disease — Payments: $1,988